Deoxycholate enhancement of an intermediate of peptidoglycan synthesis in Micrococcus luteus  by Thorpe, S.J. & Perkins, H.R.
Volume 105. number 1 FEBS LETTERS September 1979 
DEOXYCHOLATE ENHANCEMENT OF AN INTERMEDIATE OF PEPTIDOGLYCAN 
SYNTHESISIN MICROCOCCUSLUTEUS 
S. J. THORPE and H. R. PERKINS 
Department ofMicrobiology, Life Sciences Building, University of Liverpool, Liverpool L69 3BX, England 
Received 12 July 1979 
1. Introduction 
The synthesis of peptidoglycan by wall plus mem- 
brane preparations [l] is known to yield polymer 
soluble in cold aqueous sodium dodecylsulphate 
(SDS) and also a residue, presumably of material 
crosslinked to the pre-existing wall, that cannot be 
extracted even by hot aqueous SDS [2]. The cold 
SDS-soluble fraction is thought to consist of uncross- 
linked peptidoglycan chains that have not been 
attached to the preformed wall by transpeptidation, 
probably because of partial disruption of the wall/ 
membrane interface [2]. In the presence of penicillin, 
synthesis of crosslinked material decreased and a con- 
comitant increase in the SDS-soluble fraction occurred 
[2,3]. In an attempt to dissociate some of the reac- 
tions involved in peptidoglycan synthesis deoxycholate 
(DOC) was added to a wall plus membrane prepara- 
tion synthesising peptidoglycan, and the reaction 
mixture was treated sequentially with cold and hot 
SDS [2] to yield 3 separate fractions: a cold 5% SDS- 
soluble fraction; a hot (100°C for 15 min) 1% SDS- 
soluble fraction; and a residual hot SDS-insoluble 
fraction. In the absence of DOC, the majority of 
incorporation was into the hot SDS-insoluble and 
cold SDS-soluble fractions of peptidoglycan with a 
very small amount into the hot SDS-soluble fraction. 
However, in the presence of 0.25% DOC, incorpora- 
tion into the hot SDS-soluble fraction increased 
> 1 S-fold and synthesis of the other fractions was 
almost totally inhibited. The majority of the material 
in the hot SDS-soluble fraction was polymeric. Pulse- 
chase experiments showed it to be an intermediate in 
peptidoglycan synthesis. It had muramic acid at its 
reducing end, which was linked by a mild acid-labile 
bond, probably to undecaprenol. 
2. Materials and methods 
Micrococcus luteus NCTC 2665 was grown, har- 
vested and the wall plus membrane preparations 
isolated as in [l-3]. The complete reaction mixture 
for peptidoglycan synthesis contained (in 200 ~1 final 
vol.) 50 mM Tris/HCl (pH 7.8), 20 mM Mg&, 1 mM 
2-mercaptoethanol, 100 mM NH&I, 1.5 mM ATP, 
UDP-N-acetyl- [ 14C]glucosamine (UDP- [ i4C]GlcNAc, 
Radiochemical Centre, Amersham, 10 nmol, 12 dpm/ 
pmol), UDP-N-acetylmuramyl-L-alanyl-D-isogluta- 
myl-L-lysyl-D-alanyl-D-alanine (UDP-MurNAc 
pentapeptide, prepared as in [2,4]) (100 nmol), 
glycine (500 nmol) and wall plus membrane prepara- 
tion (100 ~1, 3-7 mg protein/ml). The suspensions 
were incubated at 28°C for 30 min, treated with 
0.2 ml 10% (w/v) SDS and centrifuged. The SDS was 
precipitated from the supernatant by cooling to 0°C 
and removed by centrifuging. To remove unchanged 
precursor, the resulting supernatant was applied to a 
paper chromatogram and developed for 2-3 days in 
solvent A, isobutyric acid : 0.5 M ammonia (5 :3, 
v/v). The material remaining on the origin, corrected 
for losses, was taken as the cold SDS-soluble fraction. 
The wall/membrane pellet from the original suspension 
was washed once with 0.5 ml 50 mM Tris/HCl buffer 
(pH 7.8) containing 20 mM MgClz and 1 mM 
2-mercaptoethanol (TMM buffer), to which 1% SDS 
had been added, and 4 times with TMM buffer. It was 
then resuspended in 0.5 ml TMM buffer containing 
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1% SDS, heated for 15 min at lOO”C, cooled and 
centrifuged. The supernatant was the hot SDS-soluble 
fraction and the final pellet washed once in TMM 
buffer and twice in water (0.5 ml), the hot SDS- 
insoluble. 
Samples for reduction were treated with KB3H4 
(10 mCi/mmol; 0.1 M) in 12.5 mM NaOH at 4°C for 
6 h [S]. After destruction of excess reagent by acidi- 
fication, the reduced material was hydrolysed in 4 M 
HCl for 4 h at 100°C and the HCl then removed in 
vacua. The hydrolysate was fractionated on a column 
(0.8 X 20 cm) of Dowex 50 X 2 (100-400 mesh) [S]. 
Radioactivity was measured in a scintillation 
counter (Intertechnique), areas of paper chrolnatograms 
being placed in scintillation fluid containing 2(4’-t- 
butylphenyl)-5(4”-biphenyl)-I ,3,4-oxadiazole (butyl- 
PBD) 4 g in I 1 of toluene and aqueous samples in 
aqueous scintillant (butyl-PBD 6 g, toluene 1 1, Triton 
X-100 0.5 1, water 150 ml). 
3. Results and discussion 
Peptidoglycan was synthesised by a wall plus mem- 
brane preparation of M. luteus in the presence of con- 
centrations of DOC up to 0.5% (w/v). Increasing con- 
centrations of DOC inhibited incorporation into the 
hot SDS-insoluble and the cold SDS-soluble fractions 
giving complete inhibition at 0.3%, but in the hot 
SDS-soluble fraction incorporation rose to a maximum 
at 0.25% DOC and thereafter declined (fig. 1 a). Thus 
DOC appeared to disorganize the wall synthesising 
apparatus and to prevent either of the final products 
observed [2,3] from appearing. The hot SDS-soluble 
fraction evidently represents a distinct population of 
peptidoglycan that can only be freed from the wall 
plus membrane preparation by hot, rather than cold, 
SDS. Why heat is necessary for its release is not 
known. Perhaps there is associated protein, which 
requires heat for complete denaturation in SDS before 
the peptidoglycan can be released. 
In the absence of DOC, benzylpenicillin inhibited 
formation of the hot SDS-insoluble peptido~ycan 
and increased the cold SDS-soluble material as 
reported [l-3] but the hot SDS-soluble fraction 
remained very small (fig.1 b). The effects of increasing 
concentrations of DOC on incorporation into all 3 
fractions of peptido~ycan were largely unaffected by 
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Fig.1. Effect of DOC on peptidoglycan synthesis by a wall 
plus membrane preparation: (a) in the absence and (b) in the 
presence of benzylpenicillin (10 pg/ml). The peptidoglycan 
was fractionated with SDS as described. The amount of [ ‘T]- 
GlcNAc incorporated in each assay into hot SDS-insoluble 
(*), cold SDS-soluble (A) and hot SDS-soluble (o) peptido- 
glycan was determined. 
the simultaneous presence of benzylpenicillin (10 pg/ 
ml) (fig.1 b). Penicillin is thought to act by inhibiting 
the transpeptidation of peptido~ycan [. 1 ] and since 
the drug did not affect synthesis of the hot SDS- 
soluble fraction, formation of this fraction is unlikely 
to involve transpeptidation. 
To find out whether the hot SDS-soluble material 
was an intermediate in peptidoglycan synthesis, pulse- 
chase experiments were carried out. Peptido~ycan 
synthesised as before was pulse-labelled from UDP- 
[‘4C]GlcNAc for 30 min in the presence of 0.25% 
DOG. 85-90% of the incorporation was into the hot 
SDS-soluble fraction. After centrifugation the super- 
natant was removed and the pellets were washed once 
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Fig.2. Pulse-chase of hot SDS-soluble peptidoglycan into cold 
SDS-soluble and SDS-insoluble fractions. Wall membrane 
preparations labelled from UDP-[ “C]GlcNAc in the presence 
of 0.25% DOC were washed as described and re-incubated in 
the presence of excess unlabelled nucleotide precursors with 
(closed symbols) and without (open symbols) benzylpenicillin 
(10 pg/ml). At intervals samples were fractionated with SDS 
and radioactivities were measured. Hot SDS-soluble fraction 
(0, 6). Cold SDS-soluble fraction (A, A). Hot SDS-insoluble 
fraction (o, n ). 
with 1 ml TMM buffer. Each pellet was resuspended 
in 0.2 ml TMM buffer containing 100 mM NH&l, 
15 mM ATP, UDP-MurNAc-pentapeptide (200 nmol), 
unlabelled UDP-GlcNAc (1 pmol) and glycine 
(500 nmol). Incubation was continued for < 2 h, 
reactions being stopped by addition of 0.2 ml 10% 
SDS. Label originally in the hot SDS-soluble fraction 
appeared in both the cold SDS-soluble and the hot 
SDS-insoluble fractions (fig.2). In a control prepara- 
tion without the initial labelling, peptidoglycan was 
synthesised from labelled precursors after removal 
of the 0.25% DOC. The ratio of incorporation into 
the hot SDS-insoluble and cold SDS-soluble fractions 
was the same in the control as in the pulse-chased 
preparation. Thus even after removal of the DOC, the 
ratio of incorporation into cold SDS-soluble relative 
to hot SDS-insoluble material was higher than in 
preparations never treated with bile-salt (fig. 1). This 
suggests that the effect of DOC upon the orientation 
of the enzyme system that normally transfers the 
polymeric material from the membrane to the wall is 
only partially reversible by simple washing. The effects 
of benzylpenicillin added after the removal of DOC 
was also examined. Chase preparations (fig.2) and 
controls in which synthesis from new precursors was 
measured were affected similarly, incorporation into 
the cold SDS-soluble fraction being increased at the 
expense of the hot SDS-insoluble fraction. 
If, in the absence of DOC, the small amount of hot 
SDS-soluble fraction was pulsed with radioactivity 
then this too diminished during a chase incubation. 
Hence we conclude that the hot SDS-soluble fraction 
contains an intermediate in peptidoglycan synthesis 
which can be linked to the wall and that the linkage 
process is subject, in part, to inhibition by benzyl- 
penicillin. Experiments with Pseudomonas aeruginosa 
[6] also described a hot SDS-soluble peptidoglycan 
fraction that could be chased completely into an 
SDS-insoluble fraction, thus probably being similar to 
the intermediate we describe. 
When the hot SDS-soluble fraction labelled in the 
presence of 0.25% DOC was chromatographed in 
solvent A, 90% remained at the origin and the remaining 
10% had RF 0.26. Similarly, 86% was excluded from 
a Sephadex G-50 column (3 X 30 cm) eluted with 
water and 14%, which was completely included, also 
chromatographed with RF 0.26 in solvent A. When 
the material excluded by Sephadex G-50 was applied 
to a Sephadex G-100 column (2.2 X 55 cm) and 
eluted with 0.1 M NaCl, a broad peak of included 
material was obtained. Digestion of this material by 
lysozyme (100 pg/ml, 37°C 48 h in ammonium 
acetate buffer 0.1 M (pH 6.5) yielded only 2 peaks of 
radioactivity after paper chromatography in solvent A. 
The major peak (RF 0.5 1) corresponded in mobility 
to disaccharide pentapeptide GP2 [2,7], and a minor 
peak (RF 0.85) to lipid intermediate, i.e., disaccharide 
(pentapeptide)pyrophosphate-undecaprenol. In two 
experiments the ratios of radioactivity found in the 
lipid intermediate to total radioactivity gave values of 
46 and 63 disaccharides for the length of the unde- 
graded polymer. The average biosynthetic chainlength 
of hot SDS-insoluble peptidoglycan synthesised in the 
absence of penicillin was shown to be 66 disaccharides 
[2], a value which agrees well with a role for the hot 
SDS-soluble fraction as an intermediate in the forma- 
tion of crosslinked peptidoglycan. A lower chain- 
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length (26-28 disaccharides) was observed for cold 
SDS-sohrbfe material [2] but since this fraction is 
probably an artefact of the wall~membrane preparation 
(see section 1) differences are hkely to occur. Addi- 
tional factars in the present experiments include the 
use of DOC and the possible loss of a proportion of 
the undecaprenol during the fractionation procedure. 
Material excluded from Sephadex G-SO as described 
above was reduced with KB3H4 and hydrolysed. A 
small amount of muramitol was detected on subse- 
quent fractionation on Dowex 50. However, when 
the reduction step was preceded by heating with 
0.1 M HCI for 2 h at 40°C 181, the amount of 
n~ura~nito~ detected increased o-fold. These findings 
imply that the muramic acid at the reducing end of 
the intermediate has its reducing group blocked by a 
mild acid-labile linkage, probably to undecaprenol. 
An ohgomeric intermediate in peptidoglycan 
synthesis was first described in ~~~~~~~~ ~ega~er~~F~ 
[9j_ ft was extractable with SDS at 32°C could be 
chased into SDS-insoluble material and consisted 
mainly of an oligomer, 12 disaccharides in length. 
The intermediate described here is similar in many 
ways, but we have not as yet obtained a definitive 
value for the chainlength. 
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